BioAtla BCAB Peer Comparison

NASDAQ BCAB
$1.40 +0.08 (+6.06%)
At close: Sep 8, 2026 · 4:00 PM EDT
Peer Comparison

300 Comparable Companies

Industry Biotechnology

The table below compares all 300 Biotechnology companies on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 AMGN Amgen Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 236.37 Bn 27.00 6.20 222.38 Bn
2 GILD Gilead Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 187.38 Bn -64.83 6.15 184.12 Bn
3 VRTX Vertex Pharmaceuticals Inc / Ma primary H-02 Pharmaceuticals and Biotechnology HG-01 138.36 Bn 31.45 10.99 130.51 Bn
4 REGN Regeneron Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 85.09 Bn 19.66 5.48 77.10 Bn
5 ARGX Argenx Se primary H-02 Pharmaceuticals and Biotechnology HG-01 63.93 Bn 36.92 12.23 58.75 Bn
6 MRNA Moderna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 58.07 Bn -18.38 26.07 52.94 Bn
7 ALNY Alnylam Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 35.59 Bn 45.89 7.41 32.28 Bn
8 BIIB Biogen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 32.63 Bn 39.08 3.25 31.34 Bn
9 INSM INSMED Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 27.57 Bn -31.36 24.23 26.41 Bn
10 BNTX BioNTech SE primary H-02 Pharmaceuticals and Biotechnology HG-01 26.24 Bn -14.72 8.48 12.58 Bn
11 ROIV Roivant Sciences Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 25.24 Bn -16.96 2,310.98 25.93 Bn
12 ASND Ascendis Pharma A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 16.77 Bn 18.91 11.83 15.82 Bn
13 MDGL Madrigal Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 15.77 Bn -49.43 12.28 14.93 Bn
14 BBIO BridgeBio Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 14.62 Bn -21.18 20.50 13.91 Bn
15 SMMT Summit Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 13.96 Bn — — 13.27 Bn
16 BMRN Biomarin Pharmaceutical Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 12.88 Bn 176.35 3.78 12.00 Bn
17 HALO Halozyme Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 12.57 Bn 31.25 7.55 12.34 Bn
18 ARWR Arrowhead Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 12.19 Bn -45.49 18.20 10.58 Bn
19 KNSA Kiniksa Pharmaceuticals International, plc primary H-02 Pharmaceuticals and Biotechnology HG-01 12.15 Bn 74.93 14.45 11.63 Bn
20 AAVXF Abivax S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
21 APGE Apogee Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
22 PRAX Praxis Precision Medicines, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 9.82 Bn -26.87 — 9.06 Bn
23 IONS Ionis Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.62 Bn -45.28 11.01 7.57 Bn
24 PTGX Protagonist Therapeutics, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.42 Bn 87.02 33.42 9.42 Bn
25 PCVX Vaxcyte, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.86 Bn -8.36 — 8.86 Bn
26 TGTX Tg Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.57 Bn 17.97 10.72 7.89 Bn
27 IBRX ImmunityBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.51 Bn -8.55 51.33 8.15 Bn
28 IMVT Immunovant, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.10 Bn -14.99 — 8.10 Bn
29 SYRE Spyre Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.84 Bn -42.14 — 7.84 Bn
30 GIFLF Grifols SA primary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.46 9.09 Bn
31 RYTM Rhythm Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.07 Bn -33.52 29.47 6.74 Bn
32 BLRX BioLineRx Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.97 Bn -734.96 5,007.81 6.97 Bn
33 SRRK Scholar Rock Holding Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 6.73 Bn -17.90 — 6.73 Bn
34 CGON CG Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.59 Bn -29.38 1,058.74 6.59 Bn
35 MIRM Mirum Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.53 Bn -7.43 10.57 6.10 Bn
36 COGT Cogent Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.96 Bn -16.08 — 5.96 Bn
37 DBVT DBV Technologies S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.84 Bn -33.18 1,163.52 5.66 Bn
38 ORKA Oruka Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.82 Bn — — 4.09 Bn
39 XENE Xenon Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.78 Bn -16.41 — 5.78 Bn
40 PTCT Ptc Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.77 Bn 15.04 5.72 3.55 Bn
41 LGND Ligand Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 5.69 Bn 29.05 19.58 4.33 Bn
42 ERAS Erasca, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.06 Bn -17.55 — 5.06 Bn
43 CELC Celcuity Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.68 Bn -23.96 — 4.68 Bn
44 DNTH Dianthus Therapeutics, Inc. /DE/ primary H-02 Pharmaceuticals and Biotechnology HG-01 4.63 Bn — — 4.23 Bn
45 RLAY Relay Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.16 Bn -13.51 402.01 4.16 Bn
46 VKTX Viking Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.07 Bn -7.58 — 4.07 Bn
47 DYN Dyne Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.02 Bn -7.78 — 4.02 Bn
48 IDYA IDEAYA Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.84 Bn -16.67 16.41 3.01 Bn
49 AMLX Amylyx Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.80 Bn -31.20 — 3.80 Bn
50 TNGX Tango Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.79 Bn -32.98 70.47 2.78 Bn
51 RCUS Arcus Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.77 Bn -8.13 32.18 3.06 Bn
52 TLPPF Telix Pharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 3.72 Bn -521.64 4.64 3.43 Bn
53 DNLI Denali Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.56 Bn -8.16 987.61 3.56 Bn
54 ABCL AbCellera Biologics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.50 Bn -21.21 52.94 3.50 Bn
55 CLDX Celldex Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.11 Bn -10.05 19,714.47 3.11 Bn
56 IRON Disc Medicine, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.04 Bn -15.22 — 3.04 Bn
57 IMNM Immunome Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.03 Bn -11.21 593.06 2.51 Bn
58 ARQT Arcutis Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.00 Bn 109.49 6.47 2.76 Bn
59 MBX MBX Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.96 Bn -28.23 — 2.96 Bn
60 ZLAB Zai Lab Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.94 Bn -15.57 6.55 2.24 Bn
61 SLS SELLAS Life Sciences Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.80 Bn -80.78 — 2.80 Bn
62 ATAI AtaiBeckley Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.73 Bn -22.89 553.22 2.73 Bn
63 NRIX Nurix Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.71 Bn -8.51 73.73 2.27 Bn
64 VRDN Viridian Therapeutics, Inc.\DE primary H-02 Pharmaceuticals and Biotechnology HG-01 2.60 Bn -6.02 36.49 2.60 Bn
65 VERA Vera Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.59 Bn -6.44 — 2.59 Bn
66 BCRX Biocryst Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.54 Bn -6.59 4.75 2.19 Bn
67 NKTR Nektar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 2.45 Bn -20.64 44.92 1.77 Bn
68 XTLB Xtl Biopharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -2,975.41 — 2.38 Bn
69 BHVN Biohaven Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.37 Bn -4.03 — 2.10 Bn
70 OCUL Ocular Therapeutix, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.34 Bn -7.91 44.88 2.34 Bn
71 PHVS Pharvaris N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.30 Bn -10.51 — 1.93 Bn
72 KOD Kodiak Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.22 Bn -9.16 — 2.22 Bn
73 RAPP Rapport Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.19 Bn -15.84 109.75 2.19 Bn
74 ADMA Adma Biologics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.17 Bn 13.20 4.23 2.03 Bn
75 GMAB Genmab A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn 0.17 0.34 0.66 Bn
76 URGN UroGen Pharma Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn -35.67 11.42 2.05 Bn
77 ZYME Zymeworks Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn -14.21 56.15 1.81 Bn
78 ZBIO Zenas BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn -4.99 2,082.32 2.08 Bn
79 XNCR Xencor Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn -12.36 18.84 1.60 Bn
80 AGIO Agios Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.97 Bn -4.78 20.06 1.97 Bn
81 RXRX Recursion Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.94 Bn -3.72 35.35 1.39 Bn
82 VIR Vir Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.93 Bn -7.59 6.35 1.93 Bn
83 STOK Stoke Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn -9.47 67.43 1.57 Bn
84 IMCR Immunocore Holdings plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn -101.76 4.32 0.98 Bn
85 DMRA Damora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn -6.99 — 1.32 Bn
86 SNDX Syndax Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.83 Bn -10.09 7.27 1.29 Bn
87 CMPS COMPASS Pathways plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.80 Bn -4.55 — 1.80 Bn
88 INBX Inhibrx Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.78 Bn -14.23 1,370.98 1.78 Bn
89 GHRS GH Research PLC primary H-02 Pharmaceuticals and Biotechnology HG-01 1.75 Bn -27.67 — 1.39 Bn
90 SCNI Scinai Immunotherapeutics Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.74 Bn -207.39 1,008.79 1.73 Bn
91 GLPGF Lakefront Biotherapeutics NV primary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 1.50 1.73 Bn
92 TYRA Tyra Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn -12.73 — 1.71 Bn
93 NVAX Novavax Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn -6.79 4.07 0.97 Bn
94 SEPN Septerna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn -118.55 16.97 1.68 Bn
95 AAPG Ascentage Pharma Group International primary H-02 Pharmaceuticals and Biotechnology HG-01 1.66 Bn -9.11 20.12 1.38 Bn
96 ANAB Anaptysbio, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.65 Bn -68.24 8.28 1.36 Bn
97 FBRX Forte Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
98 BCAX Bicara Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.53 Bn -8.49 — 1.53 Bn
99 ABSI Absci Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn -11.47 969.66 1.31 Bn
100 RARE Ultragenyx Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn -3.37 2.10 1.22 Bn
101 AVBP ArriVent BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.50 Bn -9.00 — 1.50 Bn
102 MAZE Maze Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.45 Bn -14.58 72.74 1.45 Bn
103 CGEM Cullinan Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn -6.70 — 1.42 Bn
104 ALMS Alumis Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn -5.85 165.97 0.88 Bn
105 OMER Omeros Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn 80.09 35.55 1.37 Bn
106 VOR Vor Biopharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn -1.48 — 1.36 Bn
107 ORIC Oric Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.33 Bn -8.83 — 1.33 Bn
108 MLTX MoonLake Immunotherapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 1.28 Bn -4.18 — 0.74 Bn
109 JBIO Jade Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn -7.93 — 1.26 Bn
110 REPL Replimune Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn -4.90 — 1.26 Bn
111 MNKD Mannkind Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn -28.78 3.20 1.15 Bn
112 ANRO Alto Neuroscience, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.25 Bn -18.17 — 1.25 Bn
113 JANX Janux Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.24 Bn -12.42 51.51 1.24 Bn
114 CRVS Corvus Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.21 Bn -27.82 — 1.00 Bn
115 CLYM Climb Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn -20.55 — 1.18 Bn
116 GLUE Monte Rosa Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn -9.12 41.06 0.55 Bn
117 SVRA Savara Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.10 Bn -9.77 — 1.10 Bn
118 OKYO OKYO Pharma Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 1.06 Bn -118.02 — 1.06 Bn
119 ABUS Arbutus Biopharma Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 6.67 5.60 0.93 Bn
120 GERN Geron Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn -15.63 4.14 0.71 Bn
121 MNPR Monopar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 1.00 Bn -72.45 — 0.95 Bn
122 ARDX Ardelyx, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -16.83 2.09 0.66 Bn
123 WVE Wave Life Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -4.90 14.37 0.57 Bn
124 RIGL Rigel Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.91 Bn 2.80 3.28 0.81 Bn
125 TBPH Theravance Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.89 Bn 20.87 8.50 0.50 Bn
126 STTK Shattuck Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn -16.32 881.20 0.88 Bn
127 ACRS Aclaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.86 Bn -11.07 104.97 0.86 Bn
128 ANNX Annexon, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.85 Bn -4.78 — 0.85 Bn
129 AVTX Avalo Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.84 Bn -8.36 — 0.84 Bn
130 CTMX CytomX Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.81 Bn -10.71 44.17 0.48 Bn
131 ZURA Zura Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn -6.79 — 0.79 Bn
132 PHAR Pharming Group N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn -124.74 2.37 0.63 Bn
133 AURA Aura Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.78 Bn -6.55 — 0.71 Bn
134 ASMB Assembly Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.73 Bn 554.70 9.71 0.41 Bn
135 BBOT BridgeBio Oncology Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.72 Bn -3.61 — 0.49 Bn
136 IRWD Ironwood Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.70 Bn 3.17 1.81 0.62 Bn
137 SLN Silence Therapeutics plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.69 Bn -17.73 1,120.86 0.62 Bn
138 ALT Altimmune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.67 Bn -8.59 — 0.67 Bn
139 OCS Oculis Holding AG primary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -362,547.56 — 0.64 Bn
140 OABI OmniAb, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -12.60 16.37 0.58 Bn
141 CTNM Contineum Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -10.36 — 0.63 Bn
142 ARVN Arvinas, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn 65.43 1.94 0.05 Bn
143 VALN Valneva SE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -10.13 3.65 0.47 Bn
144 TECX Tectonic Therapeutic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn -6.80 — 0.59 Bn
145 SGMT Sagimet Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn -12.04 — 0.58 Bn
146 CBIO Crescent Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn -3.91 557.79 0.41 Bn
147 IMUX Immunic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn -4.84 — 0.56 Bn
148 ANL Adlai Nortye Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -10.27 78.36 0.28 Bn
149 PRTA Prothena Corp Public Ltd Co primary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -11.66 9.32 0.22 Bn
150 DRUG Bright Minds Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn -15.37 — 0.50 Bn
151 KMDA Kamada Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 15.82 2.57 0.42 Bn
152 PBYI Puma Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 16.24 2.11 0.39 Bn
153 RLMD Relmada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -8.13 — 0.47 Bn
154 NEUP Neuphoria Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -19.83 — 0.45 Bn
155 AVIR Atea Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -3.41 — 0.47 Bn
156 CCCC C4 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -4.85 13.19 0.21 Bn
157 ARCT Arcturus Therapeutics Holdings Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -4.72 15.31 0.26 Bn
158 EVMN Evommune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -4.68 44.52 0.24 Bn
159 RZLT Rezolute, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -5.85 — 0.44 Bn
160 BIOA BioAge Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -4.58 42.40 0.44 Bn
161 PRLD Prelude Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -7.97 19.43 0.16 Bn
162 CMPX Compass Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.43 Bn -5.45 — 0.43 Bn
163 ENTA Enanta Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -6.49 6.28 0.22 Bn
164 LRMR Larimar Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -2.27 — 0.24 Bn
165 EYPT EyePoint, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -1.28 139.55 0.21 Bn
166 WHWK Whitehawk Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -4.78 — 0.38 Bn
167 HMDCF HUTCHMED (China) Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn — — 0.39 Bn
168 DMAC DiaMedica Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -11.03 — 0.36 Bn
169 CATX Perspective Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -3.16 — 0.36 Bn
170 AGEN Agenus Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn 3.71 2.65 0.34 Bn
171 ELDN Eledon Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -4.13 — 0.34 Bn
172 EPRX Eupraxia Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -6.68 — 0.33 Bn
173 STRO Sutro Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -2.93 3.70 0.17 Bn
174 UPB Upstream Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -2.05 104.23 0.33 Bn
175 SABS SAB Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -4.33 — 0.31 Bn
176 GALT Galectin Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -10.84 — 0.31 Bn
177 BCYC Bicycle Therapeutics Plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -1.58 4.90 0.30 Bn
178 FIXX Q32 Bio Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 64.31 — 0.19 Bn
179 ACIU AC Immune SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -5.32 13.14 0.29 Bn
180 FHTX Foghorn Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -5.29 7.86 0.22 Bn
181 MGNX Macrogenics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -17.36 1.67 0.17 Bn
182 ALXO Alx Oncology Holdings Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -3.35 — 0.28 Bn
183 TRDA Entrada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -1.82 59.24 0.28 Bn
184 CYDY CytoDyn Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -7.64 — 0.27 Bn
185 ALEC Alector, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -3.12 19.81 0.10 Bn
186 SRZN Surrozen, Inc./DE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -4.35 23.24 0.27 Bn
187 AVXL Anavex Life Sciences Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -18.88 — 0.15 Bn
188 EQ Equillium, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -13.77 — 0.25 Bn
189 PYXS Pyxis Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -3.77 17.81 0.21 Bn
190 NMRA Neumora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -1.49 — 0.25 Bn
191 CGEN Compugen Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn 6.88 3.31 0.16 Bn
192 IVVD Invivyd, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn -3.15 4.34 0.08 Bn
193 GLSI Greenwich LifeSciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -10.43 — 0.23 Bn
194 ABOS Acumen Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -2.20 — 0.23 Bn
195 CAMP Camp4 Therapeutics Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -5.11 54.32 0.23 Bn
196 FTH Faeth Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -1.16 — 0.23 Bn
197 KROS Keros Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.49 6.84 -0.03 Bn
198 CHRS Coherus Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.66 4.31 0.11 Bn
199 PRQR ProQR Therapeutics N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -4.44 10.20 0.08 Bn
200 ARMP Armata Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -3.46 — 0.19 Bn
201 PEPG PepGen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.99 — 0.22 Bn
202 PLX Protalix BioTherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 10.05 2.66 0.17 Bn
203 ANTX AN2 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -7.27 — 0.21 Bn
204 ADAG Adagene Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -13.14 32.66 0.21 Bn
205 ORMP Oramed Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 1.21 — 0.21 Bn
206 NBP NovaBridge Biosciences primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -2.47 — 0.20 Bn
207 IPHA Innate Pharma SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -1.16 60.09 0.19 Bn
208 QNCX Quince Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -2.55 — 0.34 Bn
209 NGEN Nervgen Pharma Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -116.03 — 0.19 Bn
210 KRRO Korro Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -2.61 75.57 0.06 Bn
211 MOLN Molecular Partners Ag primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -2.51 214.11 0.18 Bn
212 XLO Xilio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -5.57 2.72 0.04 Bn
213 ADCT ADC Therapeutics SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -1.42 2.28 -0.05 Bn
214 MDWD MediWound Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -4.87 14.38 0.14 Bn
215 RANI Rani Therapeutics Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -4.96 33.39 0.17 Bn
216 IFRX InflaRx N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn 0.00 2,035.87 -0.02 Bn
217 SPRB Spruce Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -2.91 — 0.16 Bn
218 NRXP NRX Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -6.25 43.96 0.12 Bn
219 MIST Milestone Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn — — -0.02 Bn
220 ENTX Entera Bio Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -10.49 — 0.14 Bn
221 OKUR OnKure Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -2.87 — -0.03 Bn
222 UNCY Unicycive Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -5.06 — 0.14 Bn
223 CUE Cue Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -1.72 6.38 0.13 Bn
224 MSLE Satellos Bioscience Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -2.56 — 0.14 Bn
225 CRBP Corbus Pharmaceuticals Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn — — -0.02 Bn
226 IBIO iBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -4.13 1,363.19 0.14 Bn
227 HURA TuHURA Biosciences, Inc./NV primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -4.47 — 0.14 Bn
228 RFL Rafael Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -5.01 136.38 0.14 Bn
229 TLSA Tiziana Life Sciences Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -6.55 — 0.12 Bn
230 BDTX Black Diamond Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -2.55 — 0.01 Bn
231 INO Inovio Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -1.50 — 0.12 Bn
232 CNTB Connect Biopharma Holdings Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -1.68 39.24 0.12 Bn
233 PMN ProMIS Neurosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -2.72 — 0.06 Bn
234 COYA Coya Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -5.00 13.92 0.07 Bn
235 GNLX GENELUX Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -3.18 — 0.11 Bn
236 ONCY Oncolytics Biotech Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -3.32 — 0.10 Bn
237 PLYX Polaryx Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -9.67 — 0.09 Bn
238 PYPD PolyPid Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn 2.80 — 0.09 Bn
239 KLRS Kalaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -1.94 — 0.09 Bn
240 OTLK Outlook Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -1.50 — 0.08 Bn
241 ACRV Acrivon Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -1.21 — 0.09 Bn
242 CTOR Citius Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -2.01 60.89 0.09 Bn
243 KZIA Kazia Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn — — 0.09 Bn
244 TLPH Talphera, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -6.42 90,632.28 0.09 Bn
245 FBIO Fortress Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 10.35 1.32 -0.06 Bn
246 RLYB Rallybio Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 2.12 139.00 0.09 Bn
247 ALDX Aldeyra Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -3.87 — 0.09 Bn
248 RVRC Revium Rx. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -118.64 — 0.09 Bn
249 ATHE Alterity Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 — 0.08 Bn
250 TELO Telomir Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -1.48 — 0.08 Bn
251 MAIA MAIA Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -2.97 — 0.05 Bn
252 INDP Indaptus Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -5.29 — 0.07 Bn
253 GANX Gain Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -4.20 — 0.08 Bn
254 DWTX Dogwood Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -2.17 — 0.08 Bn
255 CRDF Cardiff Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.79 126.99 0.07 Bn
256 SPRO Spero Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 12.11 1.50 0.02 Bn
257 XBIT XBiotech Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.62 — 0.07 Bn
258 ALGS Aligos Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -0.92 17.32 0.03 Bn
259 HRTX Heron Therapeutics, Inc. /De/ primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -7.26 0.43 0.02 Bn
260 NMAD Nomad Power Solutions, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -7.96 — 0.06 Bn
261 RNTX Rein Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -1.20 — 0.06 Bn
262 IBO Impact Biomedical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -3.04 1,632.72 0.06 Bn
263 MCRB Seres Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -0.67 29.85 0.06 Bn
264 BDRX Biodexa Pharmaceuticals Plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -6.38 — 0.04 Bn
265 ELTX Elicio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.19 — 0.03 Bn
266 SCYX Scynexis Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -3.48 2.74 -0.06 Bn
267 IMMP IMMUTEP Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.43 5.09 0.05 Bn
268 TIL Instil Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.27 — 0.05 Bn
269 PTN Palatin Technologies Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -7.93 3.86 0.05 Bn
270 ATYR aTYR PHARMA INC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.77 294.15 -0.01 Bn
271 HOWL Werewolf Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.39 2.24 0.05 Bn
272 EDSA Edesa Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -4.34 — 0.05 Bn
273 SER Serina Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.57 342.82 0.02 Bn
274 NXTC NextCure, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.95 — 0.04 Bn
275 IMA ImageneBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn — — -0.09 Bn
276 APLM Apollomics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -3.72 4.79 0.04 Bn
277 LITS Lite Strategy, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.71 — 0.03 Bn
278 MREO Mereo BioPharma Group plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.04 79.85 0.04 Bn
279 FLNA Filana Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.66 — 0.04 Bn
280 KAPA Kairos Pharma, LTD. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -6.19 0.38 0.03 Bn
281 KYNB Kyntra Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.18 4.58 0.06 Bn
282 BHST Bioharvest Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.12 0.94 0.02 Bn
283 BETRF BetterLife Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -21.82 — 0.04 Bn
284 CNTX Context Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.74 — 0.03 Bn
285 ADIL Adial Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.53 — 0.03 Bn
286 ATNM Actinium Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 2.86 0.92 0.03 Bn
287 BRNS Barinthus Biotherapeutics plc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.74 — 0.03 Bn
288 IGC IGC Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -12.26 93.50 0.03 Bn
289 YDESW YD Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn — — 0.03 Bn
290 TAOX TAO Synergies Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.31 37.53 0.03 Bn
291 CLRB Cellectar Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.24 — 0.03 Bn
292 RAPH Raphael Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -23.02 — 0.03 Bn
293 VRXA Veraxa Biotech AG - Post de-SPAC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.30 869.19 0.02 Bn
294 ABVC Abvc Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -3.54 — 0.03 Bn
295 LTRN Lantern Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.55 — 0.02 Bn
296 NNVC Nanoviricides, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.93 — 0.02 Bn
297 RDPTF Radiopharm Theranostics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.28 97.58 0.02 Bn
298 GRDX GridAI Technologies Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.14 261.63 0.03 Bn
299 CNSY Cerenome, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.73 4.80 0.01 Bn
300 EVAX Evaxion A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.31 2.67 0.01 Bn